Hinge Health Statistics
Total Valuation
Hinge Health has a market cap or net worth of $8.87 billion. The enterprise value is $8.40 billion.
| Market Cap | 8.87B |
| Enterprise Value | 8.40B |
Important Dates
The next confirmed earnings date is Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hinge Health has 80.69 million shares outstanding. The number of shares has increased by 267.86% in one year.
| Current Share Class | 62.47M |
| Shares Outstanding | 80.69M |
| Shares Change (YoY) | +267.86% |
| Shares Change (QoQ) | +1.25% |
| Owned by Insiders (%) | 17.02% |
| Owned by Institutions (%) | 81.54% |
| Float | 50.62M |
Valuation Ratios
The trailing PE ratio is 82.34 and the forward PE ratio is 42.56. Hinge Health's PEG ratio is 0.42.
| PE Ratio | 82.34 |
| Forward PE | 42.56 |
| PS Ratio | 12.32 |
| Forward PS | 9.10 |
| PB Ratio | 25.60 |
| P/TBV Ratio | 31.89 |
| P/FCF Ratio | 30.58 |
| P/OCF Ratio | 30.51 |
| PEG Ratio | 0.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 87.81, with an EV/FCF ratio of 28.96.
| EV / Earnings | 78.32 |
| EV / Sales | 11.67 |
| EV / EBITDA | 87.81 |
| EV / EBIT | 89.70 |
| EV / FCF | 28.96 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.34 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 30.38% and return on invested capital (ROIC) is 15.96%.
| Return on Equity (ROE) | 30.38% |
| Return on Assets (ROA) | 7.70% |
| Return on Invested Capital (ROIC) | 15.96% |
| Return on Capital Employed (ROCE) | 27.08% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $501,086 |
| Profits Per Employee | $74,659 |
| Employee Count | 1,437 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 7.24 |
Taxes
In the past 12 months, Hinge Health has paid $1.88 million in taxes.
| Income Tax | 1.88M |
| Effective Tax Rate | 1.69% |
Stock Price Statistics
The stock price has increased by +121.01% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +121.01% |
| 50-Day Moving Average | 95.02 |
| 200-Day Moving Average | 65.07 |
| Relative Strength Index (RSI) | 66.95 |
| Average Volume (20 Days) | 1,666,191 |
Short Selling Information
The latest short interest is 6.33 million, so 7.85% of the outstanding shares have been sold short.
| Short Interest | 6.33M |
| Short Previous Month | 5.44M |
| Short % of Shares Out | 7.85% |
| Short % of Float | 12.51% |
| Short Ratio (days to cover) | 3.39 |
Income Statement
In the last 12 months, Hinge Health had revenue of $720.06 million and earned $107.29 million in profits. Earnings per share was $1.34.
| Revenue | 720.06M |
| Gross Profit | 608.75M |
| Operating Income | 93.67M |
| Pretax Income | 110.95M |
| Net Income | 107.29M |
| EBITDA | 95.69M |
| EBIT | 93.67M |
| Earnings Per Share (EPS) | $1.34 |
Balance Sheet
The company has $389.39 million in cash and $5.89 million in debt, with a net cash position of $468.25 million or $5.80 per share.
| Cash & Cash Equivalents | 389.39M |
| Total Debt | 5.89M |
| Net Cash | 468.25M |
| Net Cash Per Share | $5.80 |
| Equity (Book Value) | 344.33M |
| Book Value Per Share | 4.29 |
| Working Capital | 161.91M |
Cash Flow
In the last 12 months, operating cash flow was $290.79 million and capital expenditures -$666,000, giving a free cash flow of $290.12 million.
| Operating Cash Flow | 290.79M |
| Capital Expenditures | -666,000 |
| Depreciation & Amortization | 2.02M |
| Net Borrowing | n/a |
| Free Cash Flow | 290.12M |
| FCF Per Share | $3.60 |
Margins
Gross margin is 84.54%, with operating and profit margins of 13.01% and 15.15%.
| Gross Margin | 84.54% |
| Operating Margin | 13.01% |
| Pretax Margin | 15.41% |
| Profit Margin | 15.15% |
| EBITDA Margin | 13.29% |
| EBIT Margin | 13.01% |
| FCF Margin | 40.29% |
Dividends & Yields
Hinge Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -267.86% |
| Shareholder Yield | -267.86% |
| Earnings Yield | 1.21% |
| FCF Yield | 3.27% |
Analyst Forecast
The average price target for Hinge Health is $112.13, which is 2.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $112.13 |
| Price Target Difference | 2.00% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 31.96% |
| EPS Growth Forecast (3Y) | 19.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hinge Health has an Altman Z-Score of 4.61 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.61 |
| Piotroski F-Score | 5 |